Rochlitz C - Search Results

1

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Rajski M, Zanetti-Dällenbach R, Vogel B, Herrmann R, Rochlitz C, Buess M. Rajski M, et al. Among authors: rochlitz c. BMC Med. 2010 Jan 5;8:1. doi: 10.1186/1741-7015-8-1. BMC Med. 2010. PMID: 20051100 Free PMC article.

2

BRCA1 mutations in a selected series of breast/ovarian cancer patients.

Garvin AM, Spycher M, Häner M, Torhorst J, Müller H, Herrmann R, Rochlitz C, Weber W, Scott RJ. Garvin AM, et al. Among authors: rochlitz c. J Med Genet. 1996 Sep;33(9):721-5. doi: 10.1136/jmg.33.9.721. J Med Genet. 1996. PMID: 8880569 Free PMC article.

3

Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells.

Jantscheff P, Herrmann R, Spagnoli G, Reuter J, Mehtali M, Courtney M, Rochlitz C. Jantscheff P, et al. Among authors: rochlitz c. Cancer Immunol Immunother. 1999 Sep;48(6):321-30. doi: 10.1007/s002620050581. Cancer Immunol Immunother. 1999. PMID: 10473807 Clinical Trial.

4

[Adjuvant systemic therapy of breast cancer--prognostic and predictive factors].

Rochlitz C. Rochlitz C. Swiss Surg. 1999;5(5):222-7. doi: 10.1024/1023-9332.5.5.222. Swiss Surg. 1999. PMID: 10546521 Clinical Trial. German.

5

Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer.

Biedermann B, Landmann C, Kann R, Passweg J, Solèr M, Lohri A, Rochlitz C, Herrmann R, Pless M. Biedermann B, et al. Among authors: rochlitz c. Radiother Oncol. 2000 Aug;56(2):169-73. doi: 10.1016/s0167-8140(00)00203-6. Radiother Oncol. 2000. PMID: 10927135

6

P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.

Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Cancer Gene Ther. 2000 Sep;7(9):1215-9. doi: 10.1038/sj.cgt.7700227. Cancer Gene Ther. 2000. PMID: 11023193 Clinical Trial.

7

Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.

Boulay JL, Mild G, Reuter J, Lagrange M, Terracciano L, Lowy A, Laffer U, Orth B, Metzger U, Stamm B, Martinoli S, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Genes Chromosomes Cancer. 2001 Jul;31(3):240-7. doi: 10.1002/gcc.1140. Genes Chromosomes Cancer. 2001. PMID: 11391794

8

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer.

Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Br J Cancer. 2002 Sep 9;87(6):630-4. doi: 10.1038/sj.bjc.6600511. Br J Cancer. 2002. PMID: 12237773 Free PMC article.

9

DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer.

Mild G, Bachmann F, Boulay JL, Glatz K, Laffer U, Lowy A, Metzger U, Reuter J, Terracciano L, Herrmann R, Rochlitz C. Mild G, et al. Among authors: rochlitz c. Int J Cancer. 2002 Nov 20;102(3):254-7. doi: 10.1002/ijc.10711. Int J Cancer. 2002. PMID: 12397645

10

SMAD7 is a prognostic marker in patients with colorectal cancer.

Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Int J Cancer. 2003 Apr 20;104(4):446-9. doi: 10.1002/ijc.10908. Int J Cancer. 2003. PMID: 12584741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results